Nancy Webb
4 Papers
55 Citations
Nancy Webb is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Efavirenz. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
Thomas B. Campbell,Laura M. Smeaton,N. Kumarasamy,Timothy P. Flanigan,Karin L. Klingman,Cynthia Firnhaber,Beatriz Grinsztejn,Mina C. Hosseinipour,Johnstone Kumwenda,Umesh G. Lalloo,Cynthia Riviere,Jorge Sanchez,Marineide Gonçalves de Melo,Khuanchai Supparatpinyo,Srikanth Tripathy,Ana Martinez,Apsara Nair,Ann Walawander,Laura Moran,Yun Chen,Wendy Snowden,James F. Rooney,Jonathan Uy,Robert T. Schooley,Victor De Gruttola,James Hakim,Edith Swann,Ronald L. Barnett,Barbara Brizz,Yvette Delph,Nikki Gettinger,Ronald T. Mitsuyasu,Susan H. Eshleman,Steven A. Safren,Susan A. Fiscus,Adriana Andrade,David W. Haas,Farida Amod,Vladimir Berthaud,Robert C. Bollinger,Yvonne J. Bryson,David D. Celentano,David Chilongozi,Myron S. Cohen,Ann C. Collier,Judith S. Currier,Susan Cu-Uvin,Joseph J. Eron,Charles Flexner,Joel E. Gallant,Roy M. Gulick,Scott M. Hammer,Irving F. Hoffman,Peter N. Kazembe,Newton Kumwenda,Javier R. Lama,Jody Lawrence,Chiedza Maponga,Francis Martinson,Kenneth H. Mayer,Karin Nielsen,Richard B. Pendame,Bharat Ramratnam,Ian Sanne,Patrice Severe,Thira Sirisanthana,Suniti Solomon,Steve Tabet,Taha E. Taha,Charles van der Horst,Christine Wanke,Joan Gormley,Cheryl Marcus,Beverly Putnam,Smanga Ntshele,Edde Loeliger,Keith A. Pappa,Nancy Webb,David Shugarts,Mark A. Winters,Renard S. Descallar,Joseph Steele,Michael Wulfsohn,Farideh Said,Yue Chen,John Martin,Norbert Bischofberger,Andrew K. Cheng,Howard Jaffe,Jabin Sharma,Selvamuthu Poongulali,Sandra W. Cardoso,Deise Lucia Faria,Sima Berendes,Kelly Burke,Rosie Mngqibisa,Cecilia Kanyama,Virginia Kayoyo,Wadzanai Samaneka,Anthony Chisada,Sharla Faesen,Suwat Chariyalertsak,Breno Santos,Rita Alves Lira,Anjali A. Joglekar,Alberto La Rosa,Rosa Infante,Mamta K. Jain,T. Petersen,Sheela Godbole,Sampada Dhayarkar,Judith Feinberg,Jenifer Baer,Richard B. Pollard,David M. Asmuth,Raman R. Gangakhedkar,Asmita Gaikwad,M. Graham Ray,Cathi Basler,Michael F. Para,Kathy J. Watson,Babafemi Taiwo,Donna V. McGregor,Henry H. Balfour,Beth D. Mullan,Ge Youl Kim,Michael K. Klebert,Gary M. Cox,Martha Silberman,Donna Mildvan,Manuel Revuelta,Karen T. Tashima,Helen Patterson,P. Jan Geiseler,Bartolo Santos,Eric S. Daar,Ruben Lopez,Laurie Frarey,David Currin,David H. Haas,Vicki L. Bailey,Pablo Tebas,Larisa Zifchak,Jolene Noel-Connor,Madeline Torres,Beverly E. Sha,Janice M. Fritsche,Michelle S. Cespedes,Janet Forcht,William A. O'Brien,Cheryl Mogridge,Christine Hurley,Roberto Corales,Maria Palmer,Mary Adams,Amneris E. Luque,Luis Lopez-Detres,Todd Stroberg +157 more
TL;DR: Findings of a randomized trial conducted in multiple countries regarding the efficacy of antiretroviral regimens with simplified dosing with positive results are reported.
Substitution of Nevirapine because of Efavirenz Toxicity in AIDS Clinical Trials Group A5095
Jeffrey T. Schouten,Amy Krambrink,Heather J. Ribaudo,Anne Kmack,Nancy Webb,Cecilia M. Shikuma,Daniel R. Kuritzkes,Daniel R. Kuritzkes,Roy M. Gulick +8 more
TL;DR: Substitution of nevirapine because of efavirenz toxicity was generally safe and efficacious and most adverse events resolved.
Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy
Susan A. Fiscus,Susan Cu-Uvin,Abel Tilahun Eshete,Michael Hughes,Yajing Bao,Mina C. Hosseinipour,Beatriz Grinsztejn,Sharlaa Badal-Faesen,Joan Dragavon,Robert W. Coombs,Ken Braun,Laura Moran,James Hakim,Timothy P. Flanigan,N. Kumarasamy,Thomas B. Campbell,Karin L. Klingman,Apsara Nair,Ann Walawander,Laura M. Smeaton,Victor De Gruttola,Ana Martinez,Edith Swann,Ronald L. Barnett,Barbara Brizz,Yvette Delph,Nikki Gettinger,Ronald T. Mitsuyasu,Susan H. Eshleman,Steven A. Safren,Adriana Andrade,David W. Haas,Farida Amod,Vladimir Berthaud,Robert C. Bollinger,Yvonne J. Bryson,David D. Celentano,David Chilongozi,Myron S. Cohen,Ann C. Collier,Judith S. Currier,Joseph J. Eron,Cynthia Firnhaber,Charles Flexner,Joel E. Gallant,Roy M. Gulick,Scott M. Hammer,Irving F. Hoffman,Peter N. Kazembe,Johnstone Kumwenda,Newton Kumwenda,Javier R. Lama,Jody Lawrence,Chiedza Maponga,Francis Martinson,Kenneth H. Mayer,Karin Nielsen,Richard B. Pendame,Bharat Ramratnam,James F. Rooney,Jorge Sanchez,Ian Sanne,Robert T. Schooley,Wendy Snowden,Suniti Solomon,Steve Tabet,Taha E. Taha,Jonathan Uy,Charles van der Horst,Christine Wanke,Joan Gormley,Cheryl Marcus,Beverly Putnam,Smanga Ntshele,Edde Loeliger,Keith A. Pappa,Nancy Webb,David Shugarts,Mark A. Winters,Renard S. Descallar,Jabin Sharma,S. Poongulali,Sandra W. Cardoso,Deise Lucia Faria,Sima Berendes,Kelly Burke,Cecelia Kanyama,Virginia Kayoyo,Wadzanai Samaneka,Anthony Chisada,Breno Santos,Alberto La Rosa,Rosa Infante,Henry H. Balfour,Beth D. Mullan,Ge-Youl Kim,Michael K. Klebert,Donna Mildvan,M. P. Revuelta,P. Jan Geiseler,Bartolo Santos,Eric S. Daar,Ruben Lopez,Laurie Frarey,David Currin,David H. Haas,Vicki L. Bailey,Pablo Tebas,Larisa Zifchak,Beverly E. Sha,Janice M. Fritsche +110 more
TL;DR: The female genital tract may serve as a reservoir of persistent HIV-1 replication during cART and affect the use of cART to prevent sexual and perinatal transmission of HIV- 1.
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).
Cecilia M. Shikuma,Yang Yang,Marshall J. Glesby,William A. Meyer,Karen T. Tashima,Heather J. Ribaudo,Nancy Webb,Barbara Bastow,Daniel R. Kuritzkes,Roy M. Gulick +9 more
TL;DR: Compared with general population norms, the metabolic dysfunctions of concern after these PI-sparing therapies were increasingly abnormal TC and lower (but improved relative to baseline) HDL-C levels.